As palbociclib treatment is known to induce G1 cell cycle arrest in Rb-sensitive cells, we observed a significant increase in the percentage of cells in G1 in parental MCF7 (Rb-sensitive) but not MDA-MDB-468 (Rb-deficient) breast cancer cells (Figure 3A,B). This evidence concerns the gene RB1 and breast carcinoma.